Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 3
1979 1
1980 11
1981 2
1982 1
1983 5
1984 8
1985 7
1986 2
1987 4
1988 8
1989 5
1990 6
1991 3
1992 4
1993 2
1994 2
1995 2
1996 1
1997 2
1998 1
1999 9
2001 7
2002 7
2003 3
2004 4
2005 6
2006 7
2007 7
2008 3
2009 7
2010 5
2011 6
2012 4
2013 4
2014 5
2015 7
2016 2
2017 2
2018 2
2019 3
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

178 results
Results by year
Filters applied: . Clear all
Page 1
Involvement of p38 MAPK in Synaptic Function and Dysfunction.
Falcicchia C, Tozzi F, Arancio O, Watterson DM, Origlia N. Falcicchia C, et al. Among authors: watterson dm. Int J Mol Sci. 2020 Aug 6;21(16):5624. doi: 10.3390/ijms21165624. Int J Mol Sci. 2020. PMID: 32781522 Free PMC article. Review.
Neuroinflammation: a potential therapeutic target.
Craft JM, Watterson DM, Van Eldik LJ. Craft JM, et al. Among authors: watterson dm. Expert Opin Ther Targets. 2005 Oct;9(5):887-900. doi: 10.1517/14728222.9.5.887. Expert Opin Ther Targets. 2005. PMID: 16185146 Review.
Targeting protein kinases in central nervous system disorders.
Chico LK, Van Eldik LJ, Watterson DM. Chico LK, et al. Among authors: watterson dm. Nat Rev Drug Discov. 2009 Nov;8(11):892-909. doi: 10.1038/nrd2999. Nat Rev Drug Discov. 2009. PMID: 19876042 Free PMC article. Review.
A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction.
Roy SM, Minasov G, Arancio O, Chico LW, Van Eldik LJ, Anderson WF, Pelletier JC, Watterson DM. Roy SM, et al. Among authors: watterson dm. J Med Chem. 2019 Jun 13;62(11):5298-5311. doi: 10.1021/acs.jmedchem.9b00058. Epub 2019 Apr 23. J Med Chem. 2019. PMID: 30978288 Free PMC article. Review.
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers.
Van Eldik LJ, Sawaki L, Bowen K, Laskowitz DT, Noveck RJ, Hauser B, Jordan L, Spears TG, Wu H, Watt K, Raja S, Roy SM, Watterson DM, Guptill JT. Van Eldik LJ, et al. Among authors: watterson dm. Clin Pharmacol Drug Dev. 2021 Feb;10(2):131-143. doi: 10.1002/cpdd.795. Epub 2020 Apr 7. Clin Pharmacol Drug Dev. 2021. PMID: 32255549 Free PMC article.
Calcium-binding proteins and the molecular basis of calcium action.
Van Eldik LJ, Zendegui JG, Marshak DR, Watterson DM. Van Eldik LJ, et al. Among authors: watterson dm. Int Rev Cytol. 1982;77:1-61. doi: 10.1016/s0074-7696(08)62463-8. Int Rev Cytol. 1982. PMID: 6757171 Review. No abstract available.
178 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page